ArticleFrontiers in oncology2021

RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma.

Ruimin Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.